BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price was up 0.7% during mid-day trading on Monday . The company traded as high as $1.56 and last traded at $1.50. Approximately 68,849 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 62,169,492 shares. The stock had previously closed at $1.49.
BioRestorative Therapies Trading Up 0.7 %
The company’s fifty day moving average is $1.50 and its 200 day moving average is $1.62. The company has a market capitalization of $2.46 billion, a P/E ratio of -1.40 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Recommended Stories
- Five stocks we like better than BioRestorative Therapies
- Stock Dividend Cuts Happen Are You Ready?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- What Are Dividends? Buy the Best Dividend Stocks
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Manufacturing Stocks Investing
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
